----

----

|  Nevada                                                   |  20-4846807                  |
|----------------------------------------------------------------|-----------------------------------|
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |

|   | Large Accelerated Filer [   ]                |   | Accelerated Filer [  ] |
|--------|--------------------------------------------------------|--------|----------------------------------|
|   |                                                   |   |                             |
|   | Non-Accelerated Filer   [   ] |   | Smaller Reporting Company [X]    |

----

|   | PART I FINANCIAL STATEMENTS                               |   |
|--------|-----------------------------------------------------------|--------|
|   |                                                      |   |
| Item 1 | Financial Statements                                      | 3      |
|   |                                                      |   |
| Item 2 | Management's Discussion and Analysis or Plan of Operation | 8      |
|   |                                                      |   |
|   | PART II OTHER INFORMATION                                 |   |
|   |                                                      |   |
| Item 1 | Legal Proceedings                                         | 12     |
| Item 2 | Changes in Securities                                     | 12     |
| Item 3 | Default upon Senior Securities                            | 12     |
| Item 4 | Submission of Matters to a Vote of Security Holders       | 12     |
| Item 5 | Other Information                                         | 12     |

----

| TRIPLE A MEDICAL, INC.                                                                                                                        |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------|--------|
| CONSOLIDATED BALANCE SHEETS                                                                                                                   |   |
| SEPTEMBER 30, 2010 AND DECEMBER 31, 2009                                                                                                      |   |
| (Unaudited)                                                                                                                                   |   |
|                                                                                                                                          |   |   |   |   |   |   |
|                                                                                                                                          |   |   |   |   |   |   |
|                                                                                                                                          |   | September 30, 2010 |   |   | December 31, 2009 |   |
| ASSETS                                                                                                                                        |   |   |   |   |   |   |
| CURRENT ASSETS:                                                                                                                               |   |   |   |   |   |   |
|     Cash and cash equivalents                                                                                             |   | $ | 4,226 |   |   | $ | 132,993 |   |
|     Accounts receivable, net of allowance for doubtful accounts of $57,705      and $17,576 |   |   | 168,289 |   |   |   | 14,522 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
|         Total Current Assets                                                                          |   |   | 172,515 |   |   |   | 147,515 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| Computer equipment, net                                                                                                                       |   |   | 684 |   |   |   | 6,844 |   |
| Developed software, net                                                                                                                       |   |   | 152,135 |   |   |   | 209,521 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| TOTAL ASSETS                                                                                                                                  |   | $ | 325,334 |   |   | $ | 363,880 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                                          |   |   |   |   |   |   |   |   |
| CURRENT LIABILITIES:                                                                                                                          |   |   |   |   |   |   |   |   |
|     Accounts payable and accrued expenses                                                                                 |   | $ | 134,793 |   |   | $ | 96,479 |   |
|     Line of credit                                                                                                        |   |   | 35,842 |   |   |   | 39,707 |   |
|     Convertible short term debt                                                                                           |   |   | - |   |   |   | 15,000 |   |
|     Advanced from shareholder                                                                                             |   |   | 3,500 |   |   |   | 22,910 |   |
|         Total Current Liabilities                                                                     |   |   | 174,135 |   |   |   | 174,096 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| STOCKHOLDERS' EQUITY                                                                                                                          |   |   |   |   |   |   |   |   |
|     Preferred stock, $0.01 par value, 20,000,000 authorized,                                                              |   |   |   |   |   |   |   |   |
|             none issued and outstanding                                           |   |   | - |   |   |   | - |   |
|     Common stock, $0.01 par value, 50,000,000 authorized,                                                                 |   |   |   |   |   |   |   |   |
|             14,270,500 and 14,050,500 issued and outstanding, respectively        |   |   | 14,271 |   |   |   | 14,051 |   |
|     Additional paid-in-capital                                                                                            |   |   | 2,011,477 |   |   |   | 1,896,697 |   |
|     Subscription deposits                                                                                                 |   |   | 2,625 |   |   |   | - |   |
|     Accumulated deficit                                                                                                   |   |   | (1,877,174 | ) |   |   | (1,720,964 | ) |
|     Total stockholders’ equity                                                                                      |   |   | 151,199 |   |   |   | 189,784 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                                    |   | $ | 325,334 |   |   | $ | 363,880 |   |
|                                                                                                                                          |   |   |   |   |   |   |   |   |
| See accompanying summary of accounting policies and notes to unaudited consolidated financial statements.                                     |   |

----

| TRIPLE A MEDICAL, INC.                                          |   |
|-----------------------------------------------------------------|--------|
| CONSOLIDATED STATEMENTS OF OPERATIONS                           |   |
| For the Three and Nine Months Ended September 30, 2010 and 2009 |   |
| (Unaudited)                                                     |   |
|                                                            |   |   |   |   |   |   |
|                                                            |   | Three Months Ended |   |   | Nine Months Ended |   |
|                                                            |   | September 30, |   |   | September 30, |   |
|                                                            |   | 2010 |   |   | 2009 |   |   | 2010 |   |   | 2009 |   |
| REVENUE                                                         |   | $ | 468,017 |   |   | $ | 256,599 |   |   | $ | 1,422,204 |   |   | $ | 647,319 |   |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| OPERATING EXPENSES:                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     Depreciation and amortization           |   |   | 21,181 |   |   |   | 21,181 |   |   |   | 63,545 |   |   |   | 63,545 |   |
|     Selling, general and administrative     |   |   | 494,424 |   |   |   | 177,570 |   |   |   | 1,514,958 |   |   |   | 819,499 |   |
|     Total operating expenses                |   |   | 515,605 |   |   |   | 198,751 |   |   |   | 1,578,503 |   |   |   | 883,044 |   |
|  Income (loss) from operations                             |   |   | (47,588 | )  |   |   | 57,848 |   |   |   | (156,299 | ) |   |   | (235,725 | ) |
|  OTHER INCOME                                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     Interest income                         |   |   | 29 |   |   |   | 3 |   |   |   | 89 |   |   |   | 14 |   |
| Net income (loss)                                               |   | $ | (47,559 | ) |   | $ | 57,851 |   |   | $ | (156,210 | ) |   | $ | (235,711 | ) |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted weighted average shares outstanding           |   |   | 14,270,500 |   |   |   | 14,050,500 |   |   |   | 14,217,057 |   |   |   | 14,050,500 |   |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per share                            |   | $ | 0.00 |   |   | $ | 0.01 |   |   | $ | (0.01 | ) |   | $ | (0.02 | ) |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

|  See accompanying summary of accounting policies and notes to unaudited consolidated financial statements. |
|-----------------------------------------------------------------------------------------------------------------|

----

| TRIPLE A MEDICAL, INC.                                                                                    |   |
|-----------------------------------------------------------------------------------------------------------|--------|
| CONSOLIDATED STATEMENTS OF CASH FLOWS                                                                     |   |
| For the Nine Months Ended September 30, 2010 and 2009                                                     |   |
| (Unaudited)                                                                                               |   |
|                                                                                                      |   |   |   |   |   |   |
|                                                                                                      |   | Nine Months Ended |   |
|                                                                                                      |   | September 30, |   |
|                                                                                                      |   | 2010 |   |   | 2009 |   |
| CASH FLOWS FROM OPERATING ACTIVITIES:                                                                     |   |   |   |   |   |   |
|     Net loss                                                                          |   | $ | (156,210 | ) |   | $ | (235,711 | ) |
|     Adjustments to reconcile net loss to net                                          |   |   |   |   |   |   |   |   |
|      cash used in operating activities:                                          |   |   |   |   |   |   |   |   |
|        Depreciation and amortization                                   |   |   | 63,546 |   |   |   | 63,546 |   |
|        Stock issued for services                                       |   |   | 85,000 |   |   |   | - |   |
|        Write-off of subscription receivable                            |   |   | - |   |   |   | 2,000 |   |
|        Bad debt expense                                                |   |   | 51,820 |   |   |   | - |   |
|        Change in operating assets and liabilities:                     |   |   |   |   |   |   |   |   |
|           Accounts receivable                           |   |   | (205,587 | ) |   |   | (68,882 | ) |
|           Accounts payable and accrued expenses         |   |   | 38,314 |   |   |   | 13,561 |   |
| NET CASH USED IN OPERATING ACTIVITIES                                                                     |   |   | (123,117 | ) |   |   | (225,486 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES:                                                                     |   |   |   |   |   |   |   |   |
|     Proceeds from sale of stock, including stock subscription deposits                |   |   | 17,625 |   |   |   | - |   |
|     Payments on line of credit                                                        |   |   | (3,865 | ) |   |   | (595 | ) |
|     Advances from shareholder                                                         |   |   | 3,500 |   |   |   | 79,050 |   |
|     Payments to shareholder                                                           |   |   | (22,910 | ) |   |   | (17,000 | ) |
|     Contributed capital                                                               |   |   | - |   |   |   | 139,000 |   |
| NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES                                                       |   |   | (5,650 | ) |   |   | 200,455 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |
| NET DECREASE IN CASH                                                                                      |   |   | (128,767 | ) |   |   | (25,031 | ) |
| CASH, BEGINNING OF PERIOD                                                                                 |   |   | 132,993 |   |   |   | 47,954 |   |
| CASH, END OF PERIOD                                                                                       |   | $ | 4,226 |   |   | $ | 22,923 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |
| NON-CASH TRANSACTIONS                                                                                     |   |   |   |   |   |   |   |   |
|    Common stock issued for conversion of debt                                              |   | $ | 15,000 |   |   | $ | - |   |
| SUPPLEMENTAL DISCLOSURES                                                                                  |   |   |   |   |   |   |   |   |
|    Interest paid                                                                           |   | $ | - |   |   | $ | - |   |
|    Income taxes paid                                                                       |   |   | - |   |   |   | - |   |
|                                                                                                      |   |   |   |   |   |   |   |   |
| See accompanying summary of accounting policies and notes to unaudited consolidated financial statements. |   |

----

----

| ·   | The Company was redomiciling from the State of Nevada to the Cayman Islands ("CAYMAN").  The change of our domicile from the State of Nevada to the CAYMAN’S will be accomplished through a merger (the “Merger”) of the Company into our wholly-owned subsidiary, Grand Silver, Inc. (“Grand Silver”), a company organized under the laws of the CAYMAN’S. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | The Company is changing its name from Triple A Medical, Inc., to Phoenix Medical Software, Inc. |
|--------------------|-------------------------------------------------------------------------------------------------|

| ·   | The Company authorized a 2 for 3 reverse stock split of the Company's outstanding common stock, changing the authorized common stock to 40,000,000 and leaving the par value of the common stock at $0.001 per share. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | The Merger will be finalized when Articles of Merger are filed with the Registrar of Corporate Affairs in the Cayman Islands and with the Department of Commerce, Division of Corporations of the State of Nevada. Under federal securities laws, the Articles of Merger cannot be filed until at least 20 days after the mailing of this Joint Information Statement/ Prospectus. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                   |   | 2010   |    |   | 2009   |   |
|------------------------|--------|--------|---------|--------|--------|--------|
|                   |   | QTD    |    |   | YTD    |   |   | QTD |   |   | YTD |   |
| Installation Contracts |   | $      | 386,516 |   |   | $      | 1,158,883 |   |   | $ | 220,900 |   |   | $ | 535,190 |   |
| Maintenance/Other      |   |   | 81,501  |   |   |   | 263,321 |   |   |   | 35,699 |   |   |   | 112,129 |   |
| TOTAL                  |   | $      | 468,017 |   |   | $      | 1,422,204 |   |   | $ | 256,599 |   |   | $ | 647,319 |   |

----

----

|   | Firstly: Accounts receivable increased by a net of $153,767 (favorable) |
|--------|-------------------------------------------------------------------------|

|   | Secondly: Cash decreased $128,767 |
|--------|-----------------------------------|

|   | Thirdly: Other Liabilities: Amounts due Shareholder: $19,410 (favorable) |
|--------|--------------------------------------------------------------------------|

|   | Fourthly: AP/Accrued Expenses: $38,314 (unfavorable) |
|--------|------------------------------------------------------|

----

----

|  Exhibit Number  |                                                                                                                                                                                     |   Name of Exhibit |
|----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|
|                       |                                                                                                                                                                                     |
|  31.1                 |  Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002.                             |
|                       |                                                                                                                                                                                     |
|  31.2                 |  Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002.                             |
|                       |                                                                                                                                                                                     |
|  32.1                 |  Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 United States Code Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002. |
|                       |                                                                                                                                                                                     |
|  99.1                 |  Addendum to the Agreement & Plan of Merger between Grand Silver, Inc. and Triple A Medical, Inc.                                                                               |

----